申请人:Astra Pharmaceuticals, Ltd.
公开号:US06063789A1
公开(公告)日:2000-05-16
Compounds of formula I ##STR1## wherein R, R.sup.1, R.sup.2, and R.sup.3 and A are as defined herein, together with pharmaceutically acceptable salts, enantiomers or tautomers are useful as pharmaceuticals, particularly in the treatment of inflammatory disease.
式I的化合物##STR1## 其中R,R.sup.1,R.sup.2和R.sup.3和A的定义如本文所述,连同药物可接受的盐,对映体或互变异构体在药物学中是有用的,特别是在治疗炎症性疾病方面。